Fig. 3
Effect of GnRH agonist treatment on cell proliferation in GBM cell line, LN229. Treatment of GBM cell line, LN229, with GnRH agonist showed (A) a maximum reduction (48.3%) in cell proliferation at 10−6 M concentration as determined by cell count using a hemocytometer. The error bars represent the standard error of mean (B) LN229 cells with and without GnRH agonist treatment, 10 × Magnification